New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For MDT;CRDC;GE;SYK;AET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 16, 2014
09:22 EDTGEGeneral Electric must answer on oil and gas focus after price slide, WSJ says
Subscribe for More Information
08:03 EDTGEGeneral Electric to acquire Oceaneering's Electric Actuator product line
Subscribe for More Information
05:56 EDTGEBoeing selects GE Aviation for ELMS on 777X
Subscribe for More Information
December 15, 2014
12:01 EDTGEBioTime unit, GE Healthcare sign set of license agreements, terms not disclosed
BioTime (BTX) announced that its subsidiary ES Cell International Pte. Ltd. and GE Healthcare (GE) have signed a set of license agreements through which GEHC received rights to ESIís stem cell patents and ESI received rights to stem cell patents controlled by GEHC, in both cases for the development of cellular assays and models derived from stem cells for use in drug discovery and toxicity screening. In addition, the agreements give GEHC the right to grant sub-licenses to the ESI patent portfolio and, in certain circumstances, ESI may further sublicense its rights for the purpose of marketing stem cell-derived products. Financial terms were not disclosed.
11:17 EDTGEGE Aviation selected by Boeing for 777x common core avionics systems
Subscribe for More Information
08:15 EDTGEGeneral Electric to host investor meeting
Subscribe for More Information
08:08 EDTGEGeneral Electric enters into IP licensing agreement with WordLogic
Subscribe for More Information
December 12, 2014
13:52 EDTAETLeerink healthcare services analyst holds an analyst/industry conference call
Subscribe for More Information
11:57 EDTGEGeneral Electric increases dividend 5% to 23c from 22c
Subscribe for More Information
11:57 EDTGEGeneral Electric increases dividend 5% to 23c from 22c
Subscribe for More Information
08:46 EDTAETAetna price target raised to $103 from $92 at Credit Suisse
Credit Suisse raised Outperform rated Aetna's price target to $103 based on updated guidance and longer term growth opportunities.
08:03 EDTAETAetna 2015 EPS guidance cautious, says Wells Fargo
Subscribe for More Information
December 11, 2014
09:05 EDTMDTMedtronic receives FDA approval for Attain Performa LV quadripolar leads
Subscribe for More Information
08:50 EDTAETAetna sees operating EPS highest in 1Q15
Subscribe for More Information
December 10, 2014
17:04 EDTAETAetna sees FY15 operating EPS at least $6.90, consensus $7.17
Sees FY15 operating revenue at least $62B, consensus $61.68B. Guidance to be confirmed at investor conference in New York on December 11.
17:02 EDTAETAetna backs FY14 operating EPS $6.60-$6.70, consensus $6.68
Subscribe for More Information
14:45 EDTAETDeal would block payments to health insurance companies, The Hill says
Subscribe for More Information
08:04 EDTGEGE Energy Financial Services, Pacifico to build second joint solar project
Subscribe for More Information
December 9, 2014
14:22 EDTAETAetna updates clinical policy for H.P. Acthar Gel
Subscribe for More Information
December 8, 2014
12:42 EDTSYKStryker resolves government investigation of OtisMed matter
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use